Breast cancer is the second common cause of cancer death in women of our country. Treatment of breast cancer depends on a number of parameters known as pathological and biological prognostic markers. Knowledge of the tumour grade would avoid under treatment of high grade carcinomas and over treatment of low grade carcinomas. Out study evaluated the feasibility of a grading system on FNA of duct cell carcinoma (NOS) and its ability to predict the histologic grade of the surgical specimens. The two widely practice grading system; Robinson's cytological grading and Scraff Bloom Richardson histological grading system were utilized for this purpose. Various reports quote varied reproducibility, ranging from 50 to 90% correlation between histologic and cytologic grade. In this study, the correlation between histologic and cytologic grade is 86.3%. In this study association between grading by FNAC and histology was statistically highly significant (χ 2 =27.66, df=1, p<0.05) sensitivity 100% and specificity 58.33%. Maximum correlation was noted in grade-I. Out of 53 cases 46 showed correlation between histologic and cytologic grading, only 7 cases showed no correlation. Histologic grade were higher than cytologic grade and maximum were within one grade difference. The reasons for discrepancies between cytologic and histologic grades appear to be due to lack of histologic parameter of mitosis in cytology. In this study, a total 57 cases of breast lump were selected for FNAC; of them 56 were female and 1 male. Out of 57 cases, 44 cases had duct cell carcinoma (DCC) and 13 cases had atypical finding such as small cells, inconspicuous nucleoli. Fifty three cases were diagnosed as DCC and lobular carcinoma by histopathological study. After confirmation of the diagnosis of breast cancer by histopathological examination ER, PR determination by immunohistochemistry was done in all 53 cases of breast cancer. FNAC has good sensitivity (85.29%) and very high specificity (100%). It can replace the open biopsy in the majority cases of clinically malignant disease.
Introduction
Breast cancer is the most common malignancyaffecting women, with more than one million cases occurring worldwide annually. Latest estimates in 2009, suggest that more than 1,050,000 new breast cancer cases occur worldwide annually, with nearly 580, 000 cases occurring in developed countries and remaining in developing countries. 1 The data from "Surveillance Epidemiology and End Results" programme of the National Cancer Institute showed that the cancer of the breast constituted 28% of all cancers in white women, 24 .9% in black women in Unites States. 2 Breast cancer constituted 15.58% of all cancers in women and ranked the top most position. 3 A recently published report said that in Bangladesh breast cancer is the second most common cancer among women and constitutes about 13-17 percent of female cancer. 4 About 22,000 women in Bangladesh are being attacked by breast cancer annually and 70 percent of them die due to lack of treatment. A lump is the first symptom in over 80 percent of all patients with lesions of the breast. Although the majority of breast lumps are not cancerous and require minimal treatment, some breast lumps require immediate attention. Prompt diagnosis and treatment of breast cancer provide better chance of long-term survival. Modern treatment options may not be available in our communities, and travel to the nearest treatment site is often expensive and time consuming. Women also report fear of rejection by their friends and families if they are diagnosed with breast cancer. [5] [6] Breast lump may be noncancerous (nonmalignant) or cancerous. Non-neoplastic breast lump such as cysts, fibroadenomas or pseudolumps, sclerosing variety of tubercular mastitis may be mistaken for malignancy. Both lumps can be evaluated by fine needle aspiration cytology (FNAC). 7 Early diagnosis of breast cancer is possible by FNAC. FNAC of the breast lump is an important part of the triple assessment of the palpable breast lump [clinical examination, images (mammography or ultrasound) and FNAC. 8 Grading is important for predicting the survival rate and mode of treatment. More than 80% of women with grade-I tumour survive 16 years whereas <60% of women with grade II and III tumour survive for same period. 9 Prognostic factors influencing the course of primary breast cancer depends on the size of the tumour, extent and spread of the tumour, microscopic features of primary tumour and cytological and histological type and grade, lymph node status and immunity of the host.
The grading system showed a high correlation with survival, as was shown in several studies. 10 Cytological scoring system was evaluated as a method of predicting histological grade and disease free survival in 79 patients with primary breast carcinoma. The value of cytological grading as an indicator of 8 years disease free survival was also measured. A good correlation was found between the cytological score and histological grade in low and moderate grade tumour. 11
Robinsons grading system used six criteria in the grading of breast adenocarcinoma. These are cellular dissociation, cell pleomorphism, nucleoli, nuclear margins, chromatin pattern and cell size. The grading system utilized cytologic material which were ethanol fixed and stained with Papanicolaou-stained. 12 Scraff Bloom Richardson grading system on biopsy specimens is in use since 1957. 13 Recently modified Scraff Bloom Richardson grading system is most widely practiced [13] [14] [15] , as assessment is based on nuclear grading which is a key prognostic factor. In Modified Bloom Richardson grading system mitotic index is used which needs assessment of cell volume. At present facilities for assessing cell volume is not possible in our department. So we used Scraff Bloom Richardson histological grading system. Robinson cytological grading system is simple and may correlate with the Scarff Bloom Richardsons grading systems as most of the criteria of both systems are related to nuclear characteristic. Both systems graded the duct cell carcinoma (NOS) into three grades (low, intermediate and high). So it is anticipated that there will be good correlation.
So, this study (retrospective and prospective) is designed to cytologically grade the duct cell carcinoma (NOS), which are already diagnosed by FNAC, by using Robinsons method of grading and to correlate it with histological grading of Scraff Bloom Richardson grading system.
The neoplastic cells of breast cancer can express a variety of receptors. 70-80% of ER/ER positive ductal carcinoma ("no special type") are usually well differentiated. Most special types of breast cancer (i.e, lobular, tubular, mucinous and papillary) are also ER-positive. 9 The receptor status of the breast cancer cells are useful for treatment and prognosis of the disease. Oestrogen (ER) and progesterone (PR) receptors are currently used in routine pathological assessment of breast cancer. 16 Steroid receptors are important markers for hormone dependence or responsiveness in breast cancer. The knowledge of the presence of ER and PR status of breast tumors is a useful means of predicting response to endocrine therapy. Patients with ER negative tumors are less likely to benefit from such treatment. 17 "Hormone therapy should be the first line of treatment for women whose tumors show sensitivity to hormonal change."
The less advanced stage or grading of breast cancer, the more likely it is to be hormone receptor positive. High grade infiltrating breast cancers are predominantly ER and PR negative. 18 If clinicians suspect the positivity or negativity of the ER/PR status from histolog ical grading can start appropriate hormone therapy for proper management of the breast cancer patients.
Objectives
The study is aimed at finding out the frequency of ER and PR status detection by Immunohistochemical technique in breast cancer patients. Inclusion criteria: Patients with duct cell carcinoma (NOS) who were initially diagnosed by FNAC with subsequent histological confirmation were included in this study.
Materials and methods
Exclusion criteria: Lump in pregnant and lactating mother or benign breast disease.
Results
The purpose of this study was to find out the relation of the status of ER and PR with the cytological and histological grading of breast cancer. All selected patients were female except one. Fine needle aspiration (FNA) were performed on these patients before surgery (After operation a final histological diagnosis was obtained).A total of 57 cases were obtained from clinically suspected patients of outpatient department of Rajshahi Medical College Hospital. Fifty three cases were selected after confirmation of diagnosis by histopathological examination. The cytological and histological variants as well as grading were done in selected 53 cases. Specimens were collected from the department of surgery of Rajshahi Medical College Hospital for the study from January 2008 to December 2009. ER, PR receptor profile was done in selected 53 cases in a private laboratory, Dhaka.
Among 53 cases cytomorphological study, histological variants as well as grading and ER, PR status were done and results were presented accordingly.
Cytological findings of 57 cases of breast lump
Out of 57 cases of FNAC done, 13 cases (16.25 %) were with atypical findings and remaining 44 cases (55.00%) were duct cell carcinoma. 53 cases selected from 44 cases of ductal carcinoma and remaining 9 cases from atypical finding which were diagnosed as duct cell carcinoma by routine histopathology.
Sensitivity =100%
Positive predictive value = 92.98% Histological grading classified into two groups, low grade (I+II) and high grade (III). 26 In histological grading, out of 53 cases 41 cases (77.36%) were low grade and 12 cases (22.64%) were high grade. The relation between histological grading and ER/PR was found to be statistically not significant (χ 2 =1.73, df=1, p> 0.05) but low histological grade tumours showed more positivity than high grade histological grade tumours. In the study of Lozowski (1987) 26 showed that a strong relationship between the histologic grade and the demonstration of ER/PR positivity. Among 35 ER/PR positive cases, 18 cases were scoring 4-6 and 15 cases were 2-3 and remaining 2 cases were 7-8. In this study, scoring system was done by quick scores.
The prevalence of hormone receptor-positive breast cancer in Asian countries has been found to be lower than the western world. Christopher et al 2003 have documented a prevalence of 76-78% of hormone receptor-positive breast cancers in the United States. In my study the relation between histological grading and ER/PR was found to be statistically not significant (χ 2 =1.73, df=1, p>0.05) due to small number of sample size but low histological grade tumours showed more positivity than high grade histological grade tumours. In this study, clearly showed that low grade tumours express high receptor status and high grade tumours show low receptor level.
Discussion
Breast cancer is the second common cause of cancer death in women of our country. 18 Treatment of breast cancer depends on a number of parameters known as pathological and biological prognostic markers. Knowledge of the tumour grade would avoid under treatment of high grade carcinomas and over treatment of low grade carcinomas.
Out study evaluated the feasibility of a grading system on FNA of duct cell carcinoma (NOS) and its ability to predict the histologic grade of the surgical specimens. The two widely practice grading system; Robinson's cytological grading and Scraff Bloom Richardson histological grading system were utilized for this purpose. Various reports quote varied reproducibility, ranging from 50 to 90% correlation between histologic and cytologic grade. [20] [21] [22] In this study, the correlation between histologic and cytologic grade is 86.3%.
In this study association between grading by FNAC and histology was statistically highly significant (χ 2 =27.66, df=1, p<0.05) sensitivity 100% and specificity 58.33%. Maximum correlation was noted in grade-I. Out of 53 cases 46 showed correlation between histologic and cytologic grading, only 7 cases showed no correlation. Histologic grade were higher than cytologic grade and maximum were within one grade difference. The reasons for discrepancies between cytologic and histologic grades appear to be due to lack of histologic parameter of mitosis in cytology. In this study, a total 57 cases of breast lump were selected for FNAC; of them 56 were female and 1 male. 
Conclusion
The present study shows that grading of breast carcinoma on FNAC can be a useful complement to preoperative assessment of breast carcinoma. It also reveals that cytological grade can be useful when neoadjuvant therapy is planned, as an alternative to histological grading.
Histological grading is considered as the gold standard and best parameter for predicting prognosis in clinical out-come. Better knowledge of the tumour grade would avoid over treatment of low grade carcinoma and under treatment of high grade carcinoma. Histological grading is helpful in the assessment of the ER/PR status because less differentiated (high grade) tumours show significantly lower levels of ER and PR. 17 Measurement of ER/PR status of breast cancer is expansive. If clinicians suspect the positivity or negativity of the ER/PR status from histological grading can start appropriate hormone therapy for proper management of the breast cancer patients.
